These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31549881)

  • 1. Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements.
    Chen F; Yang Y; Zhao Y; Pei L; Yan H
    DNA Cell Biol; 2019 Nov; 38(11):1387-1401. PubMed ID: 31549881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
    Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
    BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
    Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
    Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
    Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
    Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
    O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
    Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer.
    Li XT; Zhang JT; Yan HH; Su J; Cheng ML; Sun QH; Zhong WZ; Wu YL; Zhang DX; Hou DJ
    Cancer Treat Res Commun; 2021; 26():100297. PubMed ID: 33385734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
    Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
    Mony JT; Schuchert MJ
    Front Immunol; 2018; 9():2298. PubMed ID: 30374348
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
    Oh MS; Anker JF; Chae YK
    Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High polymerase ε expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer.
    Min KW; Kim WS; Kim DH; Son BK; Oh YH; Kwon MJ; Lee HS; Lee SE; Kim IA; Moon JY; Kim KY; Park JH
    PLoS One; 2020; 15(5):e0233066. PubMed ID: 32433714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
    Meng X; Gao Y; Yang L; Jing H; Teng F; Huang Z; Xing L
    Clin Lung Cancer; 2019 Jan; 20(1):48-58. PubMed ID: 30341017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.
    Barua S; Fang P; Sharma A; Fujimoto J; Wistuba I; Rao AUK; Lin SH
    Lung Cancer; 2018 Mar; 117():73-79. PubMed ID: 29409671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
    Li C; Pan J; Luo J; Chen X
    BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.